BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16596233)

  • 1. Characterization of the glycosylation profile of the human breast cancer cell line, MDA-231, and a bone colonizing variant.
    Carcel-Trullols J; Stanley JS; Saha R; Shaaf S; Bendre MS; Monzavi-Karbassi B; Suva LJ; Kieber-Emmons T
    Int J Oncol; 2006 May; 28(5):1173-83. PubMed ID: 16596233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo.
    Bendre MS; Gaddy-Kurten D; Mon-Foote T; Akel NS; Skinner RA; Nicholas RW; Suva LJ
    Cancer Res; 2002 Oct; 62(19):5571-9. PubMed ID: 12359770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
    Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T
    Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro.
    Yoneda T; Williams PJ; Hiraga T; Niewolna M; Nishimura R
    J Bone Miner Res; 2001 Aug; 16(8):1486-95. PubMed ID: 11499871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cadherin-11-mediated interactions with bone marrow stromal/osteoblastic cells support selective colonization of breast cancer cells in bone.
    Tamura D; Hiraga T; Myoui A; Yoshikawa H; Yoneda T
    Int J Oncol; 2008 Jul; 33(1):17-24. PubMed ID: 18575746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
    Buijs JT; Henriquez NV; van Overveld PG; van der Horst G; Que I; Schwaninger R; Rentsch C; Ten Dijke P; Cleton-Jansen AM; Driouch K; Lidereau R; Bachelier R; Vukicevic S; Clézardin P; Papapoulos SE; Cecchini MG; Löwik CW; van der Pluijm G
    Cancer Res; 2007 Sep; 67(18):8742-51. PubMed ID: 17875715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoprotegrin and the bone homing and colonization potential of breast cancer cells.
    Kapoor P; Suva LJ; Welch DR; Donahue HJ
    J Cell Biochem; 2008 Jan; 103(1):30-41. PubMed ID: 17471510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptome analysis reveals an osteoblast-like phenotype for human osteotropic breast cancer cells.
    Bellahcène A; Bachelier R; Detry C; Lidereau R; Clézardin P; Castronovo V
    Breast Cancer Res Treat; 2007 Jan; 101(2):135-48. PubMed ID: 17028989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALCAM, activated leukocyte cell adhesion molecule, influences the aggressive nature of breast cancer cells, a potential connection to bone metastasis.
    Davies S; Jiang WG
    Anticancer Res; 2010 Apr; 30(4):1163-8. PubMed ID: 20530423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.
    Hiraga T; Kizaka-Kondoh S; Hirota K; Hiraoka M; Yoneda T
    Cancer Res; 2007 May; 67(9):4157-63. PubMed ID: 17483326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humanized monoclonal antibody against parathyroid hormone-related protein suppresses osteolytic bone metastasis of human breast cancer cells derived from MDA-MB-231.
    Saito H; Tsunenari T; Onuma E; Sato K; Ogata E; Yamada-Okabe H
    Anticancer Res; 2005; 25(6B):3817-23. PubMed ID: 16309168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro.
    Bigelow RL; Williams BJ; Carroll JL; Daves LK; Cardelli JA
    Breast Cancer Res Treat; 2009 Sep; 117(1):31-44. PubMed ID: 18787947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic background of different cancer cell lines influences the gene set involved in chromosome 8 mediated breast tumor suppression.
    Seitz S; Korsching E; Weimer J; Jacobsen A; Arnold N; Meindl A; Arnold W; Gustavus D; Klebig C; Petersen I; Scherneck S
    Genes Chromosomes Cancer; 2006 Jun; 45(6):612-27. PubMed ID: 16552773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on beta-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells.
    Glinsky VV; Huflejt ME; Glinsky GV; Deutscher SL; Quinn TP
    Cancer Res; 2000 May; 60(10):2584-8. PubMed ID: 10825125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics.
    Nagaraja GM; Othman M; Fox BP; Alsaber R; Pellegrino CM; Zeng Y; Khanna R; Tamburini P; Swaroop A; Kandpal RP
    Oncogene; 2006 Apr; 25(16):2328-38. PubMed ID: 16314837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer.
    Hiraga T; Myoui A; Choi ME; Yoshikawa H; Yoneda T
    Cancer Res; 2006 Feb; 66(4):2067-73. PubMed ID: 16489006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase-1 is a crucial bone metastasis factor in a human breast cancer-derived highly invasive cell line.
    Okuyama N; Matsumine A; Kosugi R; Wakabayashi H; Uchida A
    Oncol Rep; 2008 Dec; 20(6):1497-504. PubMed ID: 19020733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs.
    Capulli M; Angelucci A; Driouch K; Garcia T; Clement-Lacroix P; Martella F; Ventura L; Bologna M; Flamini S; Moreschini O; Lidereau R; Ricevuto E; Muraca M; Teti A; Rucci N
    J Bone Miner Res; 2012 Nov; 27(11):2387-98. PubMed ID: 22714395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between bone metastasis from human breast cancer and integrin alpha(v)beta3 expression.
    Takayama S; Ishii S; Ikeda T; Masamura S; Doi M; Kitajima M
    Anticancer Res; 2005; 25(1A):79-83. PubMed ID: 15816522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
    Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
    Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.